YAP1 and benign prostatic hyperplasia: These findings indicated that targeting YAP1 could suppress cell growth and fibrosis, achieved by inhibiting proliferation, accelerating apoptosis, reversing EMT and decreasing ECM production, thereby preventing BPH progression.